Image 1 of 1
The Food and Drug Administration has not evaluated these statements. This product is not designed to diagnose, treat, cure, or prevent any medical condition. Not intended for human consumption.
This research blend combines BPC-157 with TB-500, a synthetic peptide fragment derived from thymosin beta-4. The formulation is intended for in vitro studies involving tissue-model dynamics, actin-related regulation, and cellular repair pathways. BPC-157 is examined for its involvement in angiogenic signaling and fibroblast activity, while TB-500 is investigated for its influence on cell-motility mechanisms and modulation of inflammatory pathways.